|
US6984754B1
(en)
|
1998-03-26 |
2006-01-10 |
University Of Saskatchewan Technologies Inc. |
Aliphatic amino carboxylic and amino phosphonic acids amino nitriles and amino tetrazoles as cellular rescue agents
|
|
CA2325943A1
(en)
*
|
1998-03-26 |
1999-09-30 |
University Of Saskatchewan Technologies Inc. |
Aliphatic amino carboxylic and amino phosphonic acids, amino nitriles and amino tetrazoles as cellular rescue agents
|
|
EP1844769A3
(en)
*
|
1998-04-14 |
2010-02-10 |
The General Hospital Corporation |
Methods for treating neuropsychiatric disorders
|
|
TW555757B
(en)
*
|
1998-07-31 |
2003-10-01 |
Akzo Nobel Nv |
Aminomethylcarboxylic acid derivatives
|
|
DE19840611A1
(de)
*
|
1998-09-05 |
2000-03-09 |
Klaus Wanner |
GABA-uptake-Inhibitoren mit Pyrrolidinstruktur
|
|
WO2001002363A2
(en)
|
1999-07-06 |
2001-01-11 |
Vertex Pharmaceuticals Incorporated |
N-substituted glycine derivatives
|
|
TWI243173B
(en)
|
1999-11-17 |
2005-11-11 |
Akzo Nobel Nv |
Spiro[2H-1-benzopyran-2,4'-piperidine] derivatives
|
|
DOP2001000189A
(es)
*
|
2000-06-30 |
2002-03-30 |
Pfizer Prod Inc |
Benzofenonas y sulfonas como inhibidores de la captación de glicina
|
|
US20020120149A1
(en)
|
2000-09-08 |
2002-08-29 |
Ali Syed M. |
Substituted hydrazine derivatives
|
|
AU2001290786A1
(en)
*
|
2000-09-14 |
2002-03-26 |
Gliatech, Inc. |
Nitrogen-containing compounds and their use as glycine transport inhibitors
|
|
AR032653A1
(es)
|
2001-02-09 |
2003-11-19 |
Telik Inc |
Inhibidores heterociclicos del trasportador de glicina 2 composiciones farmaceuticas, uso y metodos.
|
|
SI1368336T1
(sl)
*
|
2001-02-16 |
2006-10-31 |
Allelix Neuroscience Inc |
S tiofenom substituirani aminski derivati kot inhibitorji glyt-1
|
|
US6566550B2
(en)
|
2001-06-21 |
2003-05-20 |
Pfizer Inc |
Substituted aromatic ethers as inhibitors of glycine transport
|
|
ES2248493T3
(es)
|
2001-08-16 |
2006-03-16 |
Pfizer Products Inc. |
Difluorometilen-eteres aromaticos y su uso como inhibidores del transportador de glicina tipo 1.
|
|
US7189757B2
(en)
|
2001-10-16 |
2007-03-13 |
Hypnion, Inc. |
Treatment of sleep disorders using CNS target modulators
|
|
WO2003032912A2
(en)
|
2001-10-16 |
2003-04-24 |
Hypnion, Inc. |
Treatment of cns disorders using cns target modulators
|
|
US7355042B2
(en)
|
2001-10-16 |
2008-04-08 |
Hypnion, Inc. |
Treatment of CNS disorders using CNS target modulators
|
|
GB0219153D0
(en)
*
|
2002-08-16 |
2002-09-25 |
Pfizer Ltd |
Substituted glycine derivatives for use as medicaments
|
|
AU2003287023A1
(en)
|
2002-11-05 |
2004-06-03 |
Eli Lilly And Company |
3-aryloxy/ thio-2, 3-substituted propanamines and their use in inhibiting serotonin and norepinephrine reuptake
|
|
CN100439330C
(zh)
*
|
2003-04-30 |
2008-12-03 |
H.隆德贝克有限公司 |
芳族羟苯基和芳族硫基苯基衍生物
|
|
US20060223857A1
(en)
*
|
2003-08-21 |
2006-10-05 |
Michael Didriksen |
Combination of a serotonin reuptake inhibitor and a glycine transporter type 1 inhibitor for the treatment of depression
|
|
US20050080100A1
(en)
*
|
2003-10-09 |
2005-04-14 |
Pfizer Inc |
Pyridylamino compounds and methods of use thereof
|
|
AU2004281794B2
(en)
*
|
2003-10-14 |
2010-04-22 |
Pfizer Products Inc. |
Bicyclic [3.1.0] derivatives as glycine transporter inhibitors
|
|
JP2007528879A
(ja)
*
|
2004-03-12 |
2007-10-18 |
ハー・ルンドベック・アクチエゼルスカベット |
フェニルインダン誘導体
|
|
WO2005100301A1
(en)
*
|
2004-03-31 |
2005-10-27 |
Eli Lilly And Company |
2-aryloxyethyl glycine derivatives and their use as glycine transport inhibitors
|
|
EP1817030A2
(en)
|
2004-12-01 |
2007-08-15 |
Kalypsys, Inc. |
Inducible nitric oxide synthase dimerization inhibitors
|
|
UA95788C2
(en)
|
2005-12-15 |
2011-09-12 |
Ф. Хоффманн-Ля Рош Аг |
Fused pyrrole derivatives
|
|
KR101288781B1
(ko)
|
2006-06-28 |
2013-07-22 |
암젠 인크 |
글리신 수송자-1 억제제
|
|
CN102083797B
(zh)
|
2008-04-01 |
2014-06-04 |
Abbvie公司 |
四氢异喹啉、含有它们的药物组合物和它们在治疗中的用途
|
|
CN101613347B
(zh)
*
|
2008-06-23 |
2012-07-04 |
中国人民解放军军事医学科学院毒物药物研究所 |
胺类化合物及其医药用途
|
|
AR075442A1
(es)
|
2009-02-16 |
2011-03-30 |
Abbott Gmbh & Co Kg |
Derivados de aminotetralina, composiciones farmaceuticas que las contienen y sus usos en terapia
|
|
US9045459B2
(en)
|
2010-08-13 |
2015-06-02 |
AbbVie Deutschland GmbH & Co. KG |
Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
|
|
US8877794B2
(en)
|
2010-08-13 |
2014-11-04 |
Abbott Laboratories |
Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
|
|
US8846743B2
(en)
|
2010-08-13 |
2014-09-30 |
Abbott Laboratories |
Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy
|
|
US9051280B2
(en)
|
2010-08-13 |
2015-06-09 |
AbbVie Deutschland GmbH & Co. KG |
Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
|
|
US8883839B2
(en)
|
2010-08-13 |
2014-11-11 |
Abbott Laboratories |
Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
|
|
US9309200B2
(en)
|
2011-05-12 |
2016-04-12 |
AbbVie Deutschland GmbH & Co. KG |
Benzazepine derivatives, pharmaceutical compositions containing them, and their use in therapy
|
|
WO2013020930A1
(en)
|
2011-08-05 |
2013-02-14 |
Abbott Gmbh & Co. Kg |
Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy
|
|
EP2758403B1
(en)
|
2011-09-21 |
2016-04-27 |
Inception Orion, Inc. |
Tricyclic compounds useful as neurogenic and neuroprotective agents
|
|
MX2014006004A
(es)
|
2011-11-18 |
2015-04-16 |
Abbvie Deutschland |
Derivados de aminobenzociclohepteno, aminotetralina, aminoindano y fenalcilamina n-sustituidas, composiciones farmaceuticas que los contienen, y su uso en terapia.
|
|
US9365512B2
(en)
|
2012-02-13 |
2016-06-14 |
AbbVie Deutschland GmbH & Co. KG |
Isoindoline derivatives, pharmaceutical compositions containing them, and their use in therapy
|
|
US9656955B2
(en)
|
2013-03-15 |
2017-05-23 |
Abbvie Inc. |
Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy
|
|
US9650334B2
(en)
|
2013-03-15 |
2017-05-16 |
Abbvie Inc. |
Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy
|
|
CN105764895A
(zh)
|
2013-10-17 |
2016-07-13 |
艾伯维德国有限责任两合公司 |
氨基四氢化萘及氨基二氢化茚衍生物，包含其的药物组合物及其在治疗中的用途
|
|
CA2924689A1
(en)
|
2013-10-17 |
2015-04-23 |
AbbVie Deutschland GmbH & Co. KG |
Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy
|
|
CN105237418B
(zh)
*
|
2014-07-28 |
2017-05-17 |
昆明学院 |
含芳环的胺类化合物及其制备方法和应用
|
|
US20200123115A1
(en)
*
|
2017-06-26 |
2020-04-23 |
Esteve Pharmaceuticals, S.A. |
Compounds having multimodal activity against pain
|
|
WO2022187206A1
(en)
*
|
2021-03-01 |
2022-09-09 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Dual-target mu opioid and dopamine d3 receptors ligands; preparation and use thereof
|
|
US11596612B1
(en)
|
2022-03-08 |
2023-03-07 |
PTC Innovations, LLC |
Topical anesthetics
|